BUZZ-GSK rallies after Q3 earnings beat expectations
** GlaxoSmithKline (Other OTC: GLAXF - news) rises to trade up 4.2 pct after Q3 earnings beat consensus
** Q3 core EPS 23p v 19.3p expected by analysts, according to Thomson Reuters (Dusseldorf: TOC.DU - news) data
** Top riser on FTSE 100 with pharma peers also higher
** AstraZeneca (NYSE: AZN - news) up 2 pct
(RM (LSE: RM.L - news) : alasdair.pal.thomsonreuters.com@reuters.net)